Association of Cardiac Biomarkers With Structural Brain Changes and Cognitive Impairment: Results From the Hamburg City Health Study [0.03%]
心脏生物标志物与脑结构变化和认知障碍的关系：来自汉堡市健康研究的结果
Märit Jensen,Eik Vettorazzi,Philipp Weber et al.
Märit Jensen et al.
Background and objectives: Cardiovascular disease is linked to an increased risk of dementia. The aim of this study was to evaluate whether blood-based cardiac biomarkers are associated with structural brain changes and c...
Outcomes of Patients With Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation: A Multicenter Cohort Study [0.03%]
不明来源脑栓塞患者使用抗血小板药物或抗凝药物治疗的预后：一项多中心队列研究
James Ernest Siegler,Elena Badillo Goicoechea,Mary Penckofer et al.
James Ernest Siegler et al.
Background and objectives: Embolic stroke of undetermined source (ESUS) can be attributed to a variety of potential embolic sources, with differential response to anticoagulation. ...
Observational Study
Neurology. 2025 Aug 12;105(3):e213876. DOI:10.1212/WNL.0000000000213876 2025
Dementia Risk Due to Traumatic Brain Injury in Subtypes of Dementia in the Welsh Population [0.03%]
威尔士人口中痴呆亚型的创伤性脑损伤导致的痴呆风险
Emily Simmonds,Jun Han,George Kirov et al.
Emily Simmonds et al.
Background and objectives: Traumatic brain injury (TBI) can increase vulnerability to neurodegenerative disorders. The association between TBI and dementia has been previously reported, but studies have relied on self-rep...
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the Phase 3 OCARINA II Study [0.03%]
皮下给药奥克雷珠单抗治疗多发性硬化症患者的2b期OCARINA II研究结果
Scott D Newsome,Ewa Krzystanek,Krzysztof W Selmaj et al.
Scott D Newsome et al.
Published Erratum
Neurology. 2025 Aug 12;105(3):e213909. DOI:10.1212/WNL.0000000000213909 2025
Advancing Disability Equity in Neurology: An AAN Position Statement [0.03%]
神经病学中的残疾平等化：美国神经病学学会立场声明
Bhooma Rajagopalan Aravamuthan,Luke Moretti,Diana Cejas et al.
Bhooma Rajagopalan Aravamuthan et al.
Teaching NeuroImage: Vasculitic Neuropathy With Cutaneous Polyarteritis Nodosa [0.03%]
神经教学图象：具有皮肤多动脉炎肉芽肿的血管炎性神经病
Emily A Howell,Mary Megan Higginson,Emily Jernigan Elliott
Emily A Howell
Metachromatic Leukodystrophy: New Therapy Advancements and Emerging Research Directions [0.03%]
代谢性白质营养不良：新疗法进展和新兴研究方向
Marije A B C Asbreuk,Daphne H Schoenmakers,Laura Ann Adang et al.
Marije A B C Asbreuk et al.
Metachromatic leukodystrophy (MLD) is a rare autosomal recessive lysosomal storage disorder caused by disease-causing variants in the gene coding for arylsulfatase A, leading to deficient enzyme activity and subsequent accumulation of sulfa...
Spinal Muscular Atrophy Functional Composite Score Revised (SMA-FCR) in Untreated and Nusinersen-Treated Patient Cohorts [0.03%]
修订后的脊髓性肌萎缩功能综合评分（SMA-FCR）在未接受治疗和接受诺西那生钠治疗的患者群体中的评估结果
Amy Pasternak,Michael P McDermott,Jacqueline Montes et al.
Amy Pasternak et al.
Background and objectives: The Spinal Muscular Atrophy Functional Composite (SMA-FC) combines scores from the Hammersmith Functional Motor Scale Expanded (HFMSE), Upper Limb Module (ULM), and Six-Minute Walk Test (6MWT) i...
An FDG-PET-Based Machine Learning Framework to Support Neurologic Decision-Making in Alzheimer Disease and Related Disorders [0.03%]
基于FDG-PET的机器学习框架在阿尔茨海默病及相关障碍神经决策支持中的应用
Leland Barnard,Hugo Botha,Nick Corriveau-Lecavalier et al.
Leland Barnard et al.
Background and objectives: Distinguishing neurodegenerative diseases is a challenging task requiring neurologic expertise. Clinical decision support systems (CDSSs) powered by machine learning (ML) and artificial intellig...
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease [0.03%]
阿尔茨海默病中淀粉样蛋白阳性及APOE基因型的功能变化的时间进程和严重程度
Casey R Vanderlip,Craig E L Stark
Casey R Vanderlip
Background and objectives: APOE4 is the strongest genetic risk factor of sporadic Alzheimer disease (AD), associated with greater β-amyloid (Aβ) deposition and accelerated cognitive decline, especially in episodic memor...